From Casetext: Smarter Legal Research

Allergan, Inc. v. Watson Pharms., Inc.

United States Court of Appeals for the Federal Circuit
May 6, 2013
2013-1249 (Fed. Cir. May. 6, 2013)

Opinion

2013-1249

05-06-2013

ALLERGAN, INC., AND DUKE UNIVERSITY, Plaintiffs-Appellees, v. WATSON PHARMACEUTICALS, INC., now known as Actavis, Inc., WATSON LABORATORIES, INC., AND WATSON PHARMA, INC., Defendants-Appellants.


NOTE: This order is nonprecedential.

Appeal from the United States District Court for the Middle District of North Carolina in No. 12-CV-0321, Judge Catherine C. Eagles.

ON MOTION

Before LOURIE, BRYSON, AND MOORE, Circuit Judges. LOURIE, Circuit Judge.

ORDER

Allergan, Inc. et al. move to dismiss this appeal as premature. Apotex Inc. et al. and Watson Pharmaceuticals, Inc. oppose the motion.

Watson appeals from a February 4, 2013 order of the United States District Court for the Middle District of North Carolina, concluding that Watson infringed two of Allergan's patents and those patents were not invalid. At the time that order was issued, the district court had not entered judgment—and has still not entered judgment— as to Allergan's claims of infringement regarding two additional patents. Although the district court had also not acted on Allergan's request for injunctive relief at the time of the February 4, 2013 order, it has since granted Allergan a permanent injunction in this case, which the appellants have not yet appealed.

Absent final judgment or the issuance of a proper certification under Rule 54(b) of the Federal Rules of Civil Procedure, this court cannot exercise jurisdiction over the February 4, 2013 order. Accordingly, the court will dismiss the appeal for lack of jurisdiction, subject to reinstatement under the same docket number without the payment of an additional fee if, within 30 days of the date of this order, the district court either enters a final judgment or enters a proper certification under Rule 54(b) and, within 7 days of entry of judgment or certification, Watson files another notice of appeal.

Accordingly,

IT IS ORDERED THAT:

(1) The appeal is dismissed for lack of jurisdiction, subject to reinstatement under the same docket number without the payment of an additional filing fee if, within 30 days of the date of this order, the district court either enters final judgment or enters a proper certification under Rule 54(b).

(2) The parties are directed to immediately file a joint request for certification under Rule 54(b).

(3) Each side shall bear its own costs.

FOR THE COURT

__________________________

Jan Horbaly

Clerk
s19


Summaries of

Allergan, Inc. v. Watson Pharms., Inc.

United States Court of Appeals for the Federal Circuit
May 6, 2013
2013-1249 (Fed. Cir. May. 6, 2013)
Case details for

Allergan, Inc. v. Watson Pharms., Inc.

Case Details

Full title:ALLERGAN, INC., AND DUKE UNIVERSITY, Plaintiffs-Appellees, v. WATSON…

Court:United States Court of Appeals for the Federal Circuit

Date published: May 6, 2013

Citations

2013-1249 (Fed. Cir. May. 6, 2013)